Studienzentrum Bocholderstrasse
- Address
- Bocholder Strasse 158, 45355 Essen, Germany
Cardiovascular Diseases
At Studienzentrum Bocholderstrasse in Essen, the clinical research portfolio includes cardiovascular diseases with a focus on atrial fibrillation. The studies are designed to assess whether a new treatment approach can better prevent serious cardioembolic events and support improved protection against stroke-related complications.
- Study of atrial fibrillation and related risk of stroke and systemic embolism
- Evaluation of a new therapy aimed at preventing cardioembolic complications
This work reflects a clear interest in finding more effective ways to reduce the burden of thromboembolic disease in patients with heart rhythm disorders.
Virus Diseases
The site also conducts research in virus diseases, with studies centered on influenza prevention in adults with stable health conditions or increased risk of complications. The trial activity focuses on comparing vaccine responses to help confirm immunogenicity and support better seasonal protection.
- Investigation of influenza vaccine responses in adults aged 50 years and older
- Assessment of immunogenicity and protection-related immune measures across vaccine options
The research is aimed at improving confidence in vaccine performance for people who may be more vulnerable to severe influenza infection.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Top 4 of 6 therapeutic areas and 15 of 25 IMPs, ranked by number of trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 5 by active trials.
- 1AstraZeneca AB2active
lock +4 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1AstraZeneca AB2trials
lock +2 more on a paid plan
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Studienzentrum Bocholderstrasse
lock Showing 1 of 11 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 1/2 Study of the Safety, Tolerability, and Efficacy of ALN-4324 in Overweight to Obese Healthy Volunteers and Patients With Type 2 Diabetes Mellitus | Alnylam Pharmaceuticals Inc. | Phase I/II | Not Recruiting | Mar 2026 | — |
IMP list
lock Showing 1 of 25 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Pelacarsen | 2 | Unknown | 2020-03-06 | 2026-05-11 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.